Xun-Xi Lu (Xunxi Lu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Decision Making

Squamous Cell Carcinoma

Genome Wide Identification

Top Venues

Journal for immunotherapy of cancer

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Xun-Xi Lu, Zongchao Gou, Hong Chen, Li Li, Fei Chen, Chunjuan Bao, Hong Bu
Gene panel predicts neoadjuvant chemoimmunotherapy response and benefit from immunotherapy in HER2-negative breast cancer. Journal for immunotherapy of cancer 12 (8) (2024)
Xun-Xi Lu, Zongchao Gou, Hong Chen, Li Li, Fei Chen, Chunjuan Bao, Hong Bu
Gene panel predicts neoadjuvant chemoimmunotherapy response and benefit from immunotherapy in HER2-negative breast cancer. Journal for immunotherapy of cancer 12 (8) (2024)
Xun-Xi Lu, Zongchao Gou, Hong Chen, Li Li, Fei Chen, Chunjuan Bao, Hong Bu
Gene panel predicts neoadjuvant chemoimmunotherapy response and benefit from immunotherapy in HER2-negative breast cancer. Journal for immunotherapy of cancer 12 (8) (2024)
Xun-Xi Lu, Wen-Xiao Yang, Yu-Chen Pei, Hong Luo, Xiaoguang Li, Yun-Jin Wang, Guo-Liang Zhang, Hong Ling, Zhiming Shao, Xin Hu
An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression. Cancer research (2023)
Tian-Jian Yu, Ying-Ying Liu, Xiao-Guang Li, Bi Lian, Xun-Xi Lu, Xi Jin, Zhi-Ming Shao, Xin Hu, Gen-Hong Di, Yi-Zhou Jiang
PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer. Cancer research 81 (21) (2021)